Whatsapp: +86 180 3819 2068
Email: firstname.lastname@example.org »
The incidence of type 2 diabetes in an obese population over four years is decreased with orlistat (6.2%) compared to placebo (9.0%). Long-term use of orlistat also leads to a modest reduction in blood pressure (mean reductions of 2.5 and 1.9 mmHg in systolic and diastolic blood pressure respectively).
It is ok to contact this poster with commercial interests.